| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 720.30 | 19.7% | 6.4% |
| Total Income | 721.06 | 19.6% | 6.3% |
| Expenditure | 650.70 | 13.4% | 7.1% |
| PBT | 70.36 | 142.4% | 1.1% |
| Net Profit | 55.26 | 36.3% | 12.0% |
| OPM | 13.30% | 4.15pp | 0.49pp |
| NPM | 7.66% | 0.93pp | 1.59pp |
| EPS | 6.05 | 36.3% | 12.1% |
Aarti Drugs Ltd: Financial Results for Year Ended March 31, 2026
15 May 2026 · 15 May, 6:41 pm
Summary
Aarti Drugs Limited reported financial updates for Q4 & FY26.
Informational and educational content only. Not investment advice.